Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

This summary covers recent health news, including the slow adoption of gene therapy for sickle cell, Glenview Capital's ...

Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...

Current health news includes the declaration of a public health emergency in Georgia due to Hurricane Helene, the slow uptake ...

Meanwhile, in Lawton, about a dozen people showed up at the Abundant Life Christian Church to donate blood for the Sickle ...

Health care organizations continue to caution that there’s a need for blood donors to keep the emergency blood supply stable ...

Beam Therapeutics' pipeline shows promise but remains in early stages with no clinical trial data yet available. Find out why ...

The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...

September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...